Meeting on the Mesa 2020 | T-cells: challenges in bringing to market

T-cell therapies present a whole host of challenges with regards to manufacturing, distribution and ultimately bringing into a clinical setting. Helen Tayton-Martin, PhD, Adaptimmune, Oxford, UK, talks on the challenges in bringing to market and how Adaptimmune has taken action to circumvent these bottlenecks. This interview took place during the 2020 Meeting on the Mesa congress.